Carisma Therapeutics

1 follower


Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy to treat solid tumors.

Industries

Headquarters

Stage

Employees

Links

Org chart

Steven Kelly
President & CEO

Steven Kelly

Collapse
Michael Klichinsky
Co-Founder & SVP, Discovery Research
Daniel Cushing
Chief Technology & Development Officer
Richard Morris
Chief Financial Officer
Tom Wilton
Chief Business Officer
Eric Siegel
General Counsel & Corporate Secretary
Terry Shields
SVP, Human Resources
Kenneth Locke
VP, Manufacturing & Supply Chain
Maggie Wesberry Schmierer
Director Of Quality Control
Hameem Mazahreh
Senior Manager, Quality Assurance
Andrew Best
Manager, Process Development
Isaac Zentner
Associate Director, Process Development